347 related articles for article (PubMed ID: 16007211)
1. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.
Lleonart ME; Kirk GD; Villar S; Lesi OA; Dasgupta A; Goedert JJ; Mendy M; Hollstein MC; Montesano R; Groopman JD; Hainaut P; Friesen MD
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2956-62. PubMed ID: 16365016
[TBL] [Abstract][Full Text] [Related]
3. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
Hosny G; Farahat N; Tayel H; Hainaut P
Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
5. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
8. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
9. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
10. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
13. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
16. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
19. Etiology of hepatocellular carcinoma in Africa.
Olweny CL
IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
[TBL] [Abstract][Full Text] [Related]
20. [Study on p53 gene mutation in hepatocellular carcinoma patients in China].
Kang G; Fang Z; Volkmann M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):163-5. PubMed ID: 11436649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
